Related references
Note: Only part of the references are listed.Long-term efficacy of early infliximab-induced remission for refractory uveoretinitis associated with Behcet's disease
Hiroshi Keino et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2021)
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behcet's Disease
Claudia Fabiani et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2020)
Comparison of the treatment results for Behcet uveitis in patients treated with infliximab and interferon
Nilufer Yalcindag et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2020)
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behcet's syndrome
Noe Horiguchi et al.
SCIENTIFIC REPORTS (2020)
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behcet's Disease
Claudia Fabiani et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Ten-Year Retention Rate of Infliximab in Patients with Behcet's Disease-Related Uveitis
Claudia Fabiani et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behcet's Disease: National Multicenter Study of 177 Cases
Belen Atienza-Mateo et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behcet's disease: a large-scale, long-term postmarketing surveillance in Japan
Shigeaki Ohno et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Long-term efficacy and safety of infliximab and cyclosporine combination therapy for refractory uveoretinitis in Behcet's disease
Atsuko Katsuyama et al.
CLINICAL OPHTHALMOLOGY (2019)
2018 update of the EULAR recommendations for the management of Behcet's syndrome
Gulen Hatemi et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Predictors of sustained clinical response in patients with Beh double dagger et's disease-related uveitis treated with infliximab and adalimumab
Claudia Fabiani et al.
CLINICAL RHEUMATOLOGY (2018)
Reconstitution of disrupted photoreceptor layer in uveitis associated with Behcet's disease by infliximab treatment
Masaru Takeuchi et al.
BMC OPHTHALMOLOGY (2015)
Evaluation of the Long-Term Efficacy and Safety of Infliximab Treatment for Uveitis in Behcet's Disease
Masaru Takeuchi et al.
OPHTHALMOLOGY (2014)
Ocular manifestations in Behcet's disease
H. Zeghidi et al.
REVUE DE MEDECINE INTERNE (2014)
Long-term Clinical Outcomes in Patients with Refractory Uveitis Associated with Behcet Disease Treated with Infliximab
Sultan Al Rashidi et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2013)
Multicenter Study of Infliximab for Refractory Uveoretinitis in Behçet Disease
Hiroshi Goto
ARCHIVES OF OPHTHALMOLOGY (2012)
Infliximab Monotherapy Versus Infliximab and Colchicine Combination Therapy in Patients with Behcet's Disease
Masaki Takeuchi et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2012)
Efficacy of infliximab in refractory Behcet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
Fabrizio Cantini et al.
BIOLOGICS-TARGETS & THERAPY (2012)
Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment
Yukiko Yamada et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy
Hiroshi Keino et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behcet's disease: a comparative 4-week study
Nikos Markomichelakis et al.
RHEUMATOLOGY (2011)
Infliximab Effects Compared to Conventional Therapy in the Management of Retinal Vasculitis in Behcet Disease
Khalid F. Tabbara et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Ocular Inflammation in Behcet Disease: Incidence of Ocular Complications and of Loss of Visual Acuity
R. Oktay Kacmaz et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Clinical features of Chinese patients with Behcet's disease
Peizeng Yang et al.
OPHTHALMOLOGY (2008)
Safety and efficacy of infliximab therapy in active Behcet's uveitis: an open-label trial
H. Al-Rayes et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Ocular features of Behcet's disease: An international collaborative study
Nobuyoshi Kitaichi et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease -: An open-label trial
I Tugal-Tutkun et al.
ARTHRITIS AND RHEUMATISM (2005)
Comparison of patients with Behcet's disease in the 1980s and 1990s
A Yoshida et al.
OPHTHALMOLOGY (2004)
Uveitis in Behcet disease: An analysis of 880 patients.
I Tugal-Tutkun et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Share Paper
